Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analyses

Hartog, Christiane; Skupin, Helga; Natanson, Charles; Sun, Junfeng; Reinhart, Konrad
August 2012
Intensive Care Medicine;Aug2012, Vol. 38 Issue 8, p1258
Academic Journal
Purpose: Hydroxyethyl starch (HES) is a synthetic colloid used widely for resuscitation despite the availability of safer, less costly fluids. Numerous HES reviews have been published that may have influenced clinicians' practice. We have therefore examined the relationship between the methodological quality of published HES reviews, authors' potential conflicts of interest (pCOI) and the recommendations made. Methods: Systematic analysis of reviews on HES use. Results: Between 1975 and 2010, 165 reviews were published containing recommendations for or against HES use. From the 1990s onwards, favorable reviews increased from two to eight per year and HES's share of the artificial colloid market tripled from 20 to 60 %. Only 7 % (12/165) of these reviews of HES use contained meta-analyses; these 7 % had higher Overview Quality Assessment Questionnaire (OQAQ) scores [median (range) 6.5 (3-7)] than reviews without meta-analysis [2 (1-4); p < 0.001]. The rates of recommending against HES use are 83 % (10/12) in meta-analyses and 20 % (31/153) in reviews without meta-analysis ( p < 0.0001). Fourteen authors published the majority (70/124) of positive reviews, and ten of these 14 had or have since developed a pCOI with various manufacturers of HES. Conclusions: Low-quality HES reviews reached different conclusions than high-quality meta-analyses from independent entities, such as Cochrane Reviews. The majority of these low-quality positive HES reviews were written by a small group of authors, most of whom had or have since established ties to industry. The proliferation of positive HES reviews has been associated with increased utilization of an expensive therapy despite the lack of evidence for meaningful clinical benefit and increased risks. Clinicians need to be more informed that marketing efforts are potentially influencing scientific literature.


Related Articles

  • Fluids: what's new? Redhi, L. // South African Family Practice;May/Jun2013, Vol. 55 Issue 3, pS28 

    The article discusses the use of crystalloids, human albumin (HA), and non-protein or synthetic colloids in fluid replacement and resuscitation in the intraoperative settings. An overview of the types of fluids is offered. Details on the contents of colloids, the benefits of HA and advantages of...

  • Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post-hoc analyses of a randomised trial. Müller, Rasmus; Haase, Nicolai; Wetterslev, Jørn; Perner, Anders // Intensive Care Medicine;Nov2013, Vol. 39 Issue 11, p1963 

    Purpose: It has been speculated that certain subgroups of sepsis patients may benefit from treatment with hydroxyethyl starch (HES) 130/0.42, specifically in the earlier resuscitation of patients with more severely impaired circulation. Methods: This was a post-hoc, subgroup analysis of all 798...

  • Where did all the Voluven® go? Current controversies surrounding hydroxyethyl starches. Ayers, Caroline // ACORN: The Journal of Perioperative Nursing in Australia;Winter2014, Vol. 27 Issue 2, p10 

    No abstract available.

  • Hydroxyethyl Starch Production and Sales. Zhang Lun // China Chemical Reporter;6/21/2015, Vol. 26 Issue 12, p9 

    The article discusses the production and sales of hydroxyethyl starch, a plasma substitute used to treat hemorrhage, trauma, infection and toxic shock, in China. The drug is also used to treat diseases like hypotension that occurs after anesthesia and thromboangiitis obliterans. Details on the...

  • Colloids in the intensive care unit. Kruer, Rachel M.; Ensor, Christopher R. // American Journal of Health-System Pharmacy;10/1/2012, Vol. 69 Issue 19, p1635 

    Purpose. The most recent published evidence on the use of colloids versus crystalloids in critical care is reviewed, with a focus on population-dependent differences in safety and efficacy. Summary. Colloids offer a number of theoretical advantages over crystalloids for fluid resuscitation, but...

  • Meta-analyses of Hydroxyethyl Starch for Volume Resuscitation. Ioannidis, John P. A.; Zarychanski, Ryan; Turgeon, Alexis F.; Abou-Setta, Ahmed M. // JAMA: Journal of the American Medical Association;6/5/2013, Vol. 309 Issue 21, p2209 

    A letter to the editor is presented in response to an article related to the effect of hydroxy-ethyl starch administration in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis" in the previous issue and also presents a response from the authors.

  • Key Controversies in Colloid and Crystalloid Fluid Utilization. Frazee, Erin N.; Leedahl, David D.; Kashani, Kianoush B. // Hospital Pharmacy;Jun2015, Vol. 50 Issue 6, p446 

    Nearly 2 centuries have passed since the use of intravenous fluid became a foundational component of clinical practice. Despite a steady stream of published investigations on the topic, questions surrounding the choice, dose, timing, targets, and cost-effectiveness of various fluid options...

  • Hydroxyethyl Starch for Intravenous Volume Replacement. Antonelli, Massimo; Sandroni, Claudio // JAMA: Journal of the American Medical Association;2/20/2013, Vol. 309 Issue 7, p723 

    The author reflects on several issued related to the use of hydroxyethyl starch, synthetic colloids used as blood plasma substitute to compensate for blood loss. He mentions that synthetic colloids were earlier approved in 1960s for use without conducting phase three clinical trials. But...

  • Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis. Perner, Anders; Haase, Nicolai; Guttormsen, Anne B.; Tenhunen, Jyrki; Klemenzson, Gudmundur; �neman, Anders; Madsen, Kristian R.; M�ller, Morten H.; Elkj�r, Jeanie M.; Poulsen, Lone M.; Bendtsen, Asger; Winding, Robert; Steensen, Morten; Berezowicz, Pawel; S�e-Jensen, Peter; Bestle, Morten; Strand, Kristian; Wiis, J�rgen; White, Jonathan O.; Thornberg, Klaus J. // New England Journal of Medicine;7/12/2012, Vol. 367 Issue 2, p124 

    Background: Hydroxyethyl starch (HES) 130/0.42 is widely used for fluid resuscitation in intensive care units (ICUs), but its safety and efficacy have not been established in patients with severe sepsis. Methods: In this multicenter, parallel-group, blinded trial, we randomly assigned patients...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics